Compare RGCO & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGCO | FOCL |
|---|---|---|
| Founded | 1912 | 1979 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 225.0M | 206.3M |
| IPO Year | 2005 | 1998 |
| Metric | RGCO | FOCL |
|---|---|---|
| Price | $23.83 | $4.34 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $8.80 |
| AVG Volume (30 Days) | 8.2K | ★ 39.4K |
| Earning Date | 11-18-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.86% | N/A |
| EPS Growth | ★ 11.21 | N/A |
| EPS | ★ 1.37 | N/A |
| Revenue | ★ $95,334,212.00 | $70,527,000.00 |
| Revenue This Year | $15.70 | N/A |
| Revenue Next Year | $4.44 | $34.10 |
| P/E Ratio | $16.70 | ★ N/A |
| Revenue Growth | ★ 12.63 | 1.63 |
| 52 Week Low | $20.55 | $3.97 |
| 52 Week High | $27.17 | $6.40 |
| Indicator | RGCO | FOCL |
|---|---|---|
| Relative Strength Index (RSI) | 51.81 | 45.54 |
| Support Level | $20.89 | $4.01 |
| Resistance Level | $23.03 | $4.49 |
| Average True Range (ATR) | 0.72 | 0.26 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 54.78 | 27.46 |
RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.